| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 8th January 2021 | Management, Llc Newtyn | 62,846 | Open or private purchase | $4.66 | $293,050.90 |
| 7th January 2021 | Management, Llc Newtyn | 16,939 | Open or private purchase | $4.73 | $80,189.23 |
| 6th January 2021 | Management, Llc Newtyn | 67,310 | Open or private purchase | $4.63 | $311,577.99 |
| 4th January 2021 | Management, Llc Newtyn | 60,112 | Open or private purchase | $4.40 | $264,613.02 |
| 4th January 2021 | Management, Llc Newtyn | 60,112 | Open or private sale | $4.40 | $264,432.69 |
| 30th September 2020 | Management, Llc Newtyn | 3,850,000 | Disposition due to a tender of shares in a change of control transaction | $0.00 | |
| 30th September 2020 | Asset Management Lp Weiss | 801,424 | Disposition due to a tender of shares in a change of control transaction | $12.00 | $9,617,088.00 |
| 29th September 2020 | Asset Management Lp Weiss | 100,000 | Open or private sale | $12.74 | $1,273,580.00 |
| 16th June 2020 | Patrick K. Lucy | 770 | Open or private sale | $10.23 | $7,873.33 |
| 16th June 2020 | Patrick K. Lucy | 770 | Exercise of derivative | $3.38 | $2,602.60 |
Pfenex
Pfênex, Inc. engages in the research, development, and commercialization of pharmaceutical products. The company was founded on November 19, 2009 and is headquartered in San Diego, CA.
Ticker: PFNX
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1478121
Employees: 81
Exchange: NYSE American
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
We weren't able to import Fundamental data from the SEC disclosure.
There were no Red Flags found
Fundamentals
We weren't able to import Fundamental data from the SEC disclosure.